Brian Burgess

Brian Burgess

Goodwin

Contact
View Bio
RSS

Latest Posts › CARES Act

Share:

U.S. CARES Act Enables Long-Awaited OTC Drug Regulatory Modernization: Key Highlights

Subtitle F of the recently enacted U.S. CARES Act substantially reforms the regulatory framework for non-prescription drugs, representing the most significant update of the review process for over-the-counter (OTC) drugs...more

4/10/2020  /  CARES Act , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Over The Counter Drugs (OTC) , Pharmaceutical Industry , Regulatory Reform
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide